2 completed, 2 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Unknown 2 |
Follow Lumigan: new trials by email Literature Review of Lumigan trials Research Report on Lumigan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma Netarsudil Ophthalmic, Bimatoprost Ophthalmic - Normal Tension Glaucoma | Phase 4 | Unknown | Salus University | 115 | 2021-08-01 | 2021-08-06 |
| Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves Aqueous Suppressant Eye Drops - Glaucoma | Phase 4 | Unknown | Credit Valley EyeCare | 150 | 2012-02-01 | 2017-07-21 |
| Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination Bimatoprost and Bimatoprost/Timolol fixed combination. - Glaucoma, Ocular Hypertension | Phase 4 | Completed | Larissa University Hospital | 30 | 2009-07-01 | 2010-11-30 |
| Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic solution, Bimatoprost .03% sterile ophthalmic solution - Glaucoma, Ocular Hypertension | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 375 | 2002-01-01 | 2021-02-02 |
Glaucoma (4) · Ocular Hypertension (2) · Low Tension Glaucoma (1)
Credit Valley EyeCare (1) · Larissa University Hospital (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Salus University (1)
United States (2) · Canada (1) · Greece (1)
Amandeep S Rai, MD (1) · Devesh K Varma, MD FRCSC (1) · Ike K Ahmed, MD FRCSC (1) · Jingyun Wang, Ph.D (1)